Institutional & Family Asset Management, LLC Amgen Inc Transaction History

Institutional & Family Asset Management, LLC

$846 Million
Q2 2024

A detailed history of Institutional & Family Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Institutional & Family Asset Management, LLC holds 18,674 shares of AMGN stock, worth $5.5 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

18,674

Previous 19,014 1.79%

Holding current value

$5.5 Million

Previous $5.41 Million 7.92%

% of portfolio

0.69%

Previous 0.66%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 05, 2024	SELL	$262.75 - $319.31 $89,335 - $108,565	-340 Reduced 1.79%	18,674 $5.83 Million
Q1 2024 May 08, 2024	SELL	$268.87 - $324.56 $565,433 - $682,549	-2,103 Reduced 9.96%	19,014 $5.41 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $781,930 - $882,110	-3,058 Reduced 12.65%	21,117 $6.08 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $25,144 - $31,217	-115 Reduced 0.47%	24,175 $6.5 Million
Q2 2023 Aug 09, 2023	BUY	$214.27 - $253.37 $10,713 - $12,668	50 Added 0.21%	24,290 $5.39 Million
Q1 2023 May 08, 2023	BUY	$225.79 - $275.2 $83,542 - $101,824	370 Added 1.55%	24,240 $5.86 Million
Q4 2022 Feb 08, 2023	BUY	$229.03 - $291.01 $30,919 - $39,286	135 Added 0.57%	23,870 $6.27 Million
Q3 2022 Nov 07, 2022	BUY	$224.46 - $253.15 $58,359 - $65,819	260 Added 1.11%	23,735 $5.35 Million
Q2 2022 Aug 08, 2022	BUY	$230.71 - $256.74 $135,888 - $151,219	589 Added 2.57%	23,475 $5.71 Million
Q1 2022 May 11, 2022	BUY	$219.27 - $242.57 $61,614 - $68,162	281 Added 1.24%	22,886 $5.53 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $299,513 - $342,765	1,506 Added 7.14%	22,605 $5.09 Million
Q3 2021 Nov 10, 2021	BUY	$212.27 - $248.7 $27,595 - $32,331	130 Added 0.62%	21,099 $4.49 Million
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $812,391 - $901,288	3,478 Added 19.88%	20,969 $5.11 Million
Q1 2021 May 06, 2021	SELL	$221.91 - $258.6 $39,721 - $46,289	-179 Reduced 1.01%	17,491 $4.35 Million
Q4 2020 Feb 03, 2021	BUY	$216.38 - $257.67 $257,275 - $306,369	1,189 Added 7.21%	17,670 $4.06 Million
Q3 2020 Oct 30, 2020	SELL	$234.65 - $260.95 $517,872 - $575,916	-2,207 Reduced 11.81%	16,481 $4.19 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $49,452 - $60,685	250 Added 1.36%	18,688 $4.41 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $92,577 - $122,783	508 Added 2.83%	18,438 $3.74 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $734,702 - $944,345	-3,883 Reduced 17.8%	17,930 $4.32 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $112,300 - $134,559	-645 Reduced 2.87%	21,813 $4.22 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $89,351 - $104,739	536 Added 2.45%	22,458 $4.14 Million
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $156,090 - $175,948	863 Added 4.1%	21,922 $4.17 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $425,127 - $496,259	-2,383 Reduced 10.17%	21,059 $4.1 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $9,079 - $10,235	-49 Reduced 0.21%	23,442 $4.86 Million
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $8,136 - $9,138	-49 Reduced 0.21%	23,491 $4.34 Million
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $1.02 Million - $1.19 Million	-6,023 Reduced 20.37%	23,540 $4.01 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $1.02 Million - $1.14 Million	6,066 Added 25.82%	29,563 $5.14 Million
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $101,545 - $115,937	-607 Reduced 2.52%	23,497 $4.38 Million
Q2 2017 Aug 14, 2017	BUY	N/A	24,104	24,104 $4.15 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.

Account

Institutional & Family Asset Management, LLC Amgen Inc Transaction History